Zahra Karimi Majd

3PUBLICATIONS
9CO-AUTHORS
Biomedical imagingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 20, 2025
Cost-Utility Analysis of Mirabegron Compared to Solifenacin in the Treatment of Overactive Bladder (OAB) in Iran.

Zahra Karimi Majd, Ghader Mohammadnezhad, Saeed Taheri

|Oct 17, 2025
Developing a Discrete Choice Experiment Instrument for Evaluating Patients' Preferences in Precision Oncology.

Zahra Karimi Majd, Nazila Yousefi, Mohammad Peikanpour

|Apr 07, 2021
Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis.

Soheila Rezaei, Behzad Fatemi, Zahra Karimi Majd

Pageof 1